Previous Close | 0.0550 |
Open | 0.0550 |
Bid | 0.0550 x N/A |
Ask | 0.0650 x N/A |
Day's Range | 0.0550 - 0.0650 |
52 Week Range | 0.0500 - 0.8800 |
Volume | |
Avg. Volume | 145,506 |
Market Cap | 3.988M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.20 |
VANCOUVER, British Columbia, June 15, 2022--REVITALIST LIFESTYLE AND WELLNESS LTD. ("Revitalist" or the "Company") (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is pleased to announce it has closed its second tranche of its private placement offering which was previously announced on April 6, 2022 ("Offering"), bringing the total gross proceeds raised from the Offering to $3,944,000.
VANCOUVER, British Columbia, May 30, 2022--REVITALIST LIFESTYLE AND WELLNESS LTD. ("Revitalist" or the "Company") (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), one of the largest publicly listed US based ketamine clinic operations, reported its results for the quarter ended March 31, 2022, and provided a business update. All results are reported under International Financial Reporting Standards ("IFRS") and in Canadian dollars, unless otherwise specified.
VANCOUVER, British Columbia, May 12, 2022--REVITALIST LIFESTYLE AND WELLNESS LTD. ("Revitalist" or the "Company") (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), one of the largest publicly listed US based ketamine clinic operations, is pleased to report updates on strategic initiatives accomplished in April including becoming a founding partner with the American Association of Psychedelics.